By Sneha S K

(Reuters) -Bristol Myers Squibb, Takeda Pharmaceuticals and Astex Pharmaceuticals are coming together to share proprietary data for training an artificial intelligence model to assist drug discovery and development.

The companies are joining a consortium that includes AbbVie and Johnson & Johnson , and will contribute data from several thousand experimentally determined protein–small molecule structures to train an AI model called OpenFold3, life sciences company Apheris said on Wednesday.

The initiative is based on a federated data sharing model, which enables collaboration without exposing sensitive data.

Germany-based Apheris’ computing platform enables the aggregation of diverse data sets from companies while ensuring each dataset remains securely in its original loca

See Full Page